|
SLC39A6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.945400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.306200E-01 |
| Normal-vs-Stage2 |
6.850000E-01 |
| Normal-vs-Stage3 |
7.824200E-01 |
| Normal-vs-Stage4 |
8.831600E-01 |
| Stage1-vs-Stage2 |
4.774400E-01 |
| Stage1-vs-Stage3 |
5.109000E-01 |
| Stage1-vs-Stage4 |
9.191400E-01 |
| Stage2-vs-Stage3 |
8.257000E-01 |
| Stage2-vs-Stage4 |
6.285400E-01 |
| Stage3-vs-Stage4 |
6.997800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.631000E-01 |
| Normal-vs-AfricanAmerican |
1.648030E-01 |
| Normal-vs-Asian |
9.458800E-01 |
| Caucasian-vs-AfricanAmerican |
1.380970E-01 |
| Caucasian-vs-Asian |
8.845000E-01 |
| AfricanAmerican-vs-Asian |
1.902970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.200600E-01 |
| Normal-vs-Female |
6.107200E-01 |
| Male-vs-Female |
1.294840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.763200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.936200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.008000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.211400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.395000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.183200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.507400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.784400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.266400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.920400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.444000E-02 |
| Classical-VS-Follicular |
6.80949999720681E-08 |
| Classical-VS-Other |
7.138600E-01 |
| Classical-VS-Normal |
8.808000E-02 |
| Tall-VS-Follicular |
1.047040E-01 |
| Tall-VS-Other |
8.451600E-01 |
| Tall-VS-Normal |
4.415400E-01 |
| Follicular-VS-Other |
4.871600E-01 |
| Follicular-VS-Normal |
5.263600E-03 |
| Other-VS-Normal |
9.830800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.108200E-01 |
| Normal-vs-N1 |
4.396600E-01 |
| N0-vs-N1 |
6.805200E-01 |
|
|
